These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 26212626)

  • 1. Heavy menstrual bleeding on rivaroxaban.
    Ferreira M; Barsam S; Patel JP; Czuprynska J; Roberts LN; Patel RK; Arya R
    Br J Haematol; 2016 Apr; 173(2):314-5. PubMed ID: 26212626
    [No Abstract]   [Full Text] [Related]  

  • 2. A Case Report of Henoch-Schonlein Purpura and IgA Nephropathy Associated With Rivaroxaban.
    Chung EY; Chen J; Roxburgh S
    Nephrology (Carlton); 2018 Mar; 23(3):289-290. PubMed ID: 29461002
    [No Abstract]   [Full Text] [Related]  

  • 3. Rivaroxaban for the treatment of venous thromboembolism. A "real-life" perspective in 103 patients.
    Jara-Palomares L; Sanchez-Oro-Gomez R; Elias-Hernandez T; Morillo-Guerrero R; Ferrer-Galvan M; Asensio-Cruz MI; Barrot-Cortes E; Otero-Candelera R
    Thromb Res; 2014 Sep; 134(3):617-21. PubMed ID: 25034320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of low-dose rivaroxaban in an 88-year-old female with pulmonary embolism: A case report.
    Zhou H; Wei Q; Wu H; Tang M; Yang S; Liu Y; Qin L
    Medicine (Baltimore); 2019 May; 98(20):e15705. PubMed ID: 31096518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prothrombin complex concentrate administration through intraosseous access for reversal of rivaroxaban.
    Means L; Gimbar RP
    Am J Emerg Med; 2016 Mar; 34(3):685.e1-2. PubMed ID: 26403851
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of rivaroxaban on routine coagulation screening tests using commonly used reagents.
    Platton S; Bowles L; MacCallum P
    Br J Haematol; 2017 Nov; 179(3):511-513. PubMed ID: 27392166
    [No Abstract]   [Full Text] [Related]  

  • 7. Medication mismanagement using the rivaroxaban demonstration pack.
    Nguyen TT; MacLasco A; Vitto MJ
    Am J Health Syst Pharm; 2017 Jun; 74(12):872-873. PubMed ID: 28596224
    [No Abstract]   [Full Text] [Related]  

  • 8. Heavy menstrual bleeding in women treated with rivaroxaban and vitamin K antagonists and the risk of recurrent venous thromboembolism.
    Bryk AH; Piróg M; Plens K; Undas A
    Vascul Pharmacol; 2016 Dec; 87():242-247. PubMed ID: 27865826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rivaroxaban for the treatment of venous thromboembolism. The SWIss Venous ThromboEmbolism Registry (SWIVTER).
    Kucher N; Aujesky D; Beer JH; Mazzolai L; Baldi T; Banyai M; Hayoz D; Kaeslin T; Korte W; Escher R; Husmann M; Frauchiger B; Baumgartner I; Spirk D
    Thromb Haemost; 2016 Aug; 116(3):472-9. PubMed ID: 27346301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How I treat heavy menstrual bleeding associated with anticoagulants.
    Boonyawat K; O'Brien SH; Bates SM
    Blood; 2017 Dec; 130(24):2603-2609. PubMed ID: 29092828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Practical management of rivaroxaban for the treatment of venous thromboembolism.
    Imberti D; Benedetti R
    Clin Appl Thromb Hemost; 2015 May; 21(4):309-18. PubMed ID: 24057396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe dizziness following rivaroxaban introduction in a parkinsonian patient: Drug-drug interaction?
    Lefaucheur R; Le Goff F; Gaillon G; Triquenot-Bagan A; Maltête D
    Presse Med; 2015 Nov; 44(11):1203-4. PubMed ID: 26433836
    [No Abstract]   [Full Text] [Related]  

  • 13. Rivaroxaban for the treatment of superficial vein thrombosis, experience at King's College Hospital.
    Clapham RE; Speed V; Czuprynska J; Gazes A; Guppy S; Patel RK; Rea C; Vadher B; Arya R; Roberts LN
    Br J Haematol; 2022 Jan; 196(1):e3-e6. PubMed ID: 34355385
    [No Abstract]   [Full Text] [Related]  

  • 14. Heparin-induced Thrombocytopenia Presenting With Deep Venous Thrombosis and Pulmonary Embolism Successfully Treated With Rivaroxaban: Clinical Case Report and Review of Current Experiences.
    Samoš M; Bolek T; Ivanková J; Stančiaková L; Kovář F; Galajda P; Kubisz P; Staško J; Mokáň M
    J Cardiovasc Pharmacol; 2016 Nov; 68(5):391-394. PubMed ID: 27464495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel factor xa inhibitor for the treatment of cerebral venous and sinus thrombosis: first experience in 7 patients.
    Geisbüsch C; Richter D; Herweh C; Ringleb PA; Nagel S
    Stroke; 2014 Aug; 45(8):2469-71. PubMed ID: 25070963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of leukocytoclastic vasculitis caused by novel anticoagulant rivaroxaban.
    Dean R; Messer AM; Pickett M; Jahan-Tigh R
    Dermatol Online J; 2017 Nov; 23(11):. PubMed ID: 29447643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver injury during rivaroxaban treatment in a patient with AL amyloidosis.
    Marrinan A; Shackleton L; Kelly C; Lavin M; Glavey S; Murphy P; Quinn J
    Eur J Clin Pharmacol; 2021 Jul; 77(7):1073-1076. PubMed ID: 33427957
    [No Abstract]   [Full Text] [Related]  

  • 18. Spontaneous bilateral haemothorax with haemopericardium secondary to rivaroxaban.
    Yu JH; Liu HH; Hsieh MJ; Hsieh IC; Chu PH; Chen DY
    J Clin Pharm Ther; 2020 Oct; 45(5):1175-1178. PubMed ID: 32023350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing Length of Stay Between Patients Taking Rivaroxaban and Conventional Anticoagulants for Treatment of Venous Thromboembolism.
    Desai A; Desai A; Calixte R; Aparnath M; Hindenburg A; Salzman S; Mathew JP
    Lung; 2016 Aug; 194(4):605-11. PubMed ID: 27192990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent Venous Thromboembolism in Two Patients With Cancer Taking Rivaroxaban.
    Theodorou JM; Patel Y; Ford P
    J Pharm Pract; 2017 Jun; 30(3):381-384. PubMed ID: 27026636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.